Norgestimate
ATC G03AA11 · 4 markets · 41 records
Norgestimate
Forms
GB 9 records · 1 strengths
Records without a stated strength · 1 Cilest 35microgram/250microgram tablets、Cilique 250microgram/35microgram tablets、Lizinna 250microgram/35microgram tablets、__no_trade__
CA 6 records · 3 strengths
ES 1 records · 1 strengths
- 0.25 mgtabletEDELSINE
MX 1 records · 1 strengths
Records without a stated strength · 1 PREGNOLAN
| Strength / form / release | GB | CA | ES | MX |
|---|---|---|---|---|
| 0.25 mg tablet | TRI-CIRA TRI-CIRA LO TRI-JORDYNA | EDELSINE | ||
| 0.215 mg tablet | TRI-CIRA TRI-CIRA LO TRI-JORDYNA | |||
| 0.18 mg tablet | TRI-CIRA TRI-CIRA LO TRI-JORDYNA | |||
tablet | No trade name Cilest 35microgram/250microgram tablets Cilique 250microgram/35microgram tablets+1Lizinna 250microgram/35microgram tablets | PREGNOLAN |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.